FIELD: pharmacology.
SUBSTANCE: solid dosage form comprising of 9-butylamino-3,3-dimethyl-1,2,4-trihydroacridine, calcium stearate, dicalcium phosphate dihydrate, polyvinyl pyrrolidone, sodium dodecyl sulfate, talc, milk sugar in a certain weight ratio is described. A method for preparing said solid dosage form is shown.
EFFECT: invention provides a high tablet hardness, required disintegration and high bioavailability of the active ingredient, ease of manufacture of proposed tablets.
1 tbl
Authors
Dates
2017-04-13—Published
2016-03-28—Filed